shouldiuse.io

Comparison

SBIR vs SEED - Helping Innovators turn discovery into health

SBIR and SEED - Helping Innovators turn discovery into health both land on Depends.

SBIR versus SEED - Helping Innovators turn discovery into health
CompareSBIRSEED - Helping Innovators turn discovery into health
VerdictDependsDepends
Best forUS small businesses with federal-relevant R&DUS health/biotech startups under 500 employees
Who it's not forAnyone needing cash this quarterSoftware shoppers . this is a grant program, not a tool
PrivacyNo known public vulnerabilities found in the sources reviewed.⁸No known public vulnerabilities found in the sources reviewed.
Support qualityNo support-quality evidence foundSite advertises staff application help; unverified.
Public sentimentr/SBIR users report slower timelines and a more bureaucratic process than expected, particularly around DOE awards.⁴No independent reviews of the SEED site were found; public discussion covers NIH SBIR funding generally, not this program's experience.
Biggest gotchaFalse claims in proposals carry federal fraud penalties.⁹Check eligibility first: company size, US ownership, and topic fit decide whether months of effort pay off13

Pick SBIR when

  • US small businesses with federal-relevant R&D
  • Teams seeking non-dilutive capital
  • Patient founders tolerating 6-18 month cycles
  • Defense, health, and energy tech startups

When SBIR is not a fit

  • Anyone needing cash this quarter
  • Non-US-owned small businesses
  • Teams without grant-writing or compliance bandwidth
  • Buyers shopping for software . this is a portal, not a tool

Pick SEED - Helping Innovators turn discovery into health when

  • US health/biotech startups under 500 employees
  • Academic innovators commercializing discoveries
  • Teams avoiding dilution
  • Pre-revenue R&D projects

When SEED - Helping Innovators turn discovery into health is not a fit

  • Software shoppers . this is a grant program, not a tool
  • Non-US or large (>500 employee) companies
  • Teams needing cash within weeks . federal review takes months
  • Venture-scale raises . awards are far smaller than VC rounds

Sources

  1. official
  2. official
  3. official
  4. review
  5. review
  6. news
  7. review
  8. security
  9. official
  10. news
  11. news
  12. official
  13. official
  14. About SEEDseed.nih.gov
    official
  15. review
  16. news